Dr David Gilham
Research Fellow
- Email: dgilham@picr.man.ac.uk
- Telephone: +44 (0)161 446 3239
Clinical and Experimental Immunotherapy Group
School of Cancer and Enabling Sciences
University of Manchester
Paterson Institute for Cancer Research
Wilmslow Road
Withington
Manchester
M20 4BX
Collaborators and affiliated staff
Publications
2011
- Castro, F., Al-Muftah, M., Mulryan, K., Jiang, H., Drijfhout, J., Ali, S., Rutkowski, A., Kalaitsidou, M., Gilham, D. & Stern, P (2011). Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapy. Cancer Immunol Immunother, eScholarID:144554 | DOI:10.1007/s00262-011-1167-3
- Cheadle, E., Rothwell, D., Bridgeman, J., Sheard, V., Hawkins, R. & Gilham, D (2011). Ligation of the CD2 co-stimulatory receptor enhances IL-2 production from first-generation chimeric antigen receptor T cells. Gene Ther, eScholarID:144553 | DOI:10.1038/gt.2011.192
- Gilham, D (2011). Effective adoptive T-cell therapy for cancer in the absence of host lymphodepletion. Immunotherapy, 3(2), 177-9. eScholarID:144552 | DOI:10.2217/imt.10.115